Sfoglia per Autore
B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1
1992 Tazzari P.L.; Bolognesi A.; De Totero D.; Pileri S.; Conte R.; Wijdenes J.; Herve P.; Soria M.; Stirpe F.; Gobbi M.
Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin
1992 Falini B.; Flenghi L.; Aversa F.; Barbabietola G.; Martelli M.F.; Comeli P.; Tazzari P.L.; Broe M.K.; Stein H.; Durkop H.; Pizzolo G.; Bolognesi A.; Stirpe F.; Sabattini E.; Pileri S.
Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation
1992 Tazzari P.L.; Bolognesi A.; Totero D.d.; Falini B.; Lemoli R.M.; Soria M.R.; Pileri S.; Gobbi M.; Stein H.; Flenghi L.; Martelli M.F.; Stirpe F.
Observer variation in histological assessment of Helicobacter pylori on gastric biopsies [6]
1996 Biasco G.; Paganelli G.M.; Terranova A.; Santucci R.; Renga M.; Vaira D.; Amorosi A.; Pileri S.
Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice
1996 Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B.; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B.
An epstein-barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins
1999 Tazzari P.L.; De Totero D.; Bolognesi A.; Testoni N.; Pileri S.; Roncella S.; Reato G.; Stein H.; Gobbi M.; Stirpe F.
The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma
2002 Caletti G.; Zinzani P.L.; Fusaroli P.; Buscarini E.; Parente F.; Federici T.; Peyre S.; De Angelis C.; Bonanno G.; Togliani T.; Pileri S.; Tura S.
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells
2003 Pistillo M.P.; Tazzari P.L.; Palmisano G.L.; Pierri I.; Bolognesi A.; Ferlito F.; Capanni P.; Polito L.; Ratta M.; Pileri S.; Piccioli M.; Basso G.; Rissotto L.; Conte R.; Gobbi M.; Stirpe F.; Ferrara G.B.
Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy
2003 Caletti G.; Togliani T.; Fusaroli P.; Sabattini E.; Khodadadian E.; Gamberi B.; Gobbi M.; Pileri S.
Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma
2004 ASCANI S; WENT P; LIBERATI AM; PICCALUGA PP; ZINZANI P.; PILERI SA
Challenging paradigms in lymphoma treatment
2004 BENDANDI M; PILERI SA; ZINZANI P.
Clear-cell proliferation of the lung with lymphangioleiomyomatosis-like change
2004 PILERI SA; CAVAZZA A; SCHIAVINA M; ZOMPATORI M; PEDERZOLI M; GOLDFISCHER M; SABATTINI E; ASCANI S; PASQUINELLI G.; BONETTI F; COLBY TV
Identification of outcome predictors in diffuse large B-cell lymphoma. of homogeneously treated de novo nodal tumours on tissue micro-arrays.
2004 Pileri S.A.; Dirnhofer S.; Sabattini E.; Piccaluga P.P.; Bacci F.; Agostinelli C.; Bodega L.; Orduz R.; Falini B.; Zinzani P.L.
Intravascular lymphoma: clinical presentation, natural history, management, and prognostic factors in a series of 38 cases, with special emphasis on the "cutaneous variant".
2004 Ferreri A.J.; Campo E.; Seymour J.F.; Willemze R; Illarucci F.; Ambrosetti A.;Zucca E.; Rossi G.; Lopez-Guillermo A.; Pavlosky M.A.; Geerts M.-L.; Candoni A.; Lestani M.; Asioli S.; Milani M.; Piris M.A.; Pileri S.; Facchetti F.; Cavalli F.; Ponzoni M.
Anaplastic Large Cell Lymphoma: a critical reappraisal
2004 Pileri S; Agostinelli C; Bodega L; Orduz R; Bacci F; Sabattini E; Pileri A; Giunti M; Zinzani PL; Falini B.
PAX5 Expression in acute leukemias: higher B-lineage specificity then CD79a and selective association with t(8;21)-Acute Myelogenous Leukemia.
2004 Tiacci E.; Pileri S.; Orleth A.; Pacini R.; Tabarrini A.; Frenquelli F.; Liso A.; Divero D.; Lo Coco F.; Falini B.
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
2004 ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M.
CDK9/Cyclin T1 expression during normal lymphoid differentiation and malignant transformation.
2004 Bellan C.; De Falco G.; Lazzi S.; Micheli P.; Vicidomini S.; Schürfels K.; Amato T.; Palumbo A.; Bagella L.; Sabattini E.; Bartolommei S.; Hummel M.; Pileri S.; Tosi P.; Leoncini L.; Giordano A.
Acute renal failure in a young woman with Fisher-Evans’ syndrome.
2004 De Sanctis B.A.; Mandrealo M.; Poggi C.; Pileri S.; Casanova S.; Santoro A.
Clinico-patholocal characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single instituion.
2004 Breccia M., Mandelli F., Petti M.C., D’Andrea M., Pescarmona E., Pileri S.A., Carmosino I., Russo F., Fabritiis P.D., Alimena G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1 | Tazzari P.L.; Bolognesi A.; De Totero D.; Pileri S.; Conte R.; Wijdenes J.; Herve P.; Soria M.; S...tirpe F.; Gobbi M. | 1992-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin | Falini B.; Flenghi L.; Aversa F.; Barbabietola G.; Martelli M.F.; Comeli P.; Tazzari P.L.; Broe M....K.; Stein H.; Durkop H.; Pizzolo G.; Bolognesi A.; Stirpe F.; Sabattini E.; Pileri S. | 1992-01-01 | THE LANCET | - | 1.01 Articolo in rivista | - |
| Ber‐H2 (anti‐CD30)‐saporin immunotoxin: a new tool for the the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation | Tazzari P.L.; Bolognesi A.; Totero D.d.; Falini B.; Lemoli R.M.; Soria M.R.; Pileri S.; Gobbi M.;... Stein H.; Flenghi L.; Martelli M.F.; Stirpe F. | 1992-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Observer variation in histological assessment of Helicobacter pylori on gastric biopsies [6] | Biasco G.; Paganelli G.M.; Terranova A.; Santucci R.; Renga M.; Vaira D.; Amorosi A.; Pileri S. | 1996-01-01 | THE AMERICAN JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice | Terenzi A.; Bolognesi A.; Pasqualucci L.; Flenghi L.; Pileri S.; Stein H.; Marshall K.; Bigerna B....; Polito L.; Tazzari P.L.; Martelli M.F.; Stirpe F.; Falini B. | 1996-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| An epstein-barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins | Tazzari P.L.; De Totero D.; Bolognesi A.; Testoni N.; Pileri S.; Roncella S.; Reato G.; Stein H.;... Gobbi M.; Stirpe F. | 1999-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma | Caletti G.; Zinzani P.L.; Fusaroli P.; Buscarini E.; Parente F.; Federici T.; Peyre S.; De Angeli...s C.; Bonanno G.; Togliani T.; Pileri S.; Tura S. | 2002-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells | Pistillo M.P.; Tazzari P.L.; Palmisano G.L.; Pierri I.; Bolognesi A.; Ferlito F.; Capanni P.; Pol...ito L.; Ratta M.; Pileri S.; Piccioli M.; Basso G.; Rissotto L.; Conte R.; Gobbi M.; Stirpe F.; Ferrara G.B. | 2003-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy | Caletti G.; Togliani T.; Fusaroli P.; Sabattini E.; Khodadadian E.; Gamberi B.; Gobbi M.; Pileri S. | 2003-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma | ASCANI S; WENT P; LIBERATI AM; PICCALUGA PP; ZINZANI P.; PILERI SA | 2004-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Challenging paradigms in lymphoma treatment | BENDANDI M; PILERI SA; ZINZANI P. | 2004-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Clear-cell proliferation of the lung with lymphangioleiomyomatosis-like change | PILERI SA; CAVAZZA A; SCHIAVINA M; ZOMPATORI M; PEDERZOLI M; GOLDFISCHER M; SABATTINI E; ASCANI S...; PASQUINELLI G.; BONETTI F; COLBY TV | 2004-01-01 | HISTOPATHOLOGY | - | 1.01 Articolo in rivista | - |
| Identification of outcome predictors in diffuse large B-cell lymphoma. of homogeneously treated de novo nodal tumours on tissue micro-arrays. | Pileri S.A.; Dirnhofer S.; Sabattini E.; Piccaluga P.P.; Bacci F.; Agostinelli C.; Bodega L.; Ord...uz R.; Falini B.; Zinzani P.L. | 2004-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Intravascular lymphoma: clinical presentation, natural history, management, and prognostic factors in a series of 38 cases, with special emphasis on the "cutaneous variant". | Ferreri A.J.; Campo E.; Seymour J.F.; Willemze R; Illarucci F.; Ambrosetti A.;Zucca E.; Rossi G.;... Lopez-Guillermo A.; Pavlosky M.A.; Geerts M.-L.; Candoni A.; Lestani M.; Asioli S.; Milani M.; Piris M.A.; Pileri S.; Facchetti F.; Cavalli F.; Ponzoni M. | 2004-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Anaplastic Large Cell Lymphoma: a critical reappraisal | Pileri S; Agostinelli C; Bodega L; Orduz R; Bacci F; Sabattini E; Pileri A; Giunti M; Zinzani PL;... Falini B. | 2004-01-01 | HEMATOPATHOLOGY | - | 1.01 Articolo in rivista | - |
| PAX5 Expression in acute leukemias: higher B-lineage specificity then CD79a and selective association with t(8;21)-Acute Myelogenous Leukemia. | Tiacci E.; Pileri S.; Orleth A.; Pacini R.; Tabarrini A.; Frenquelli F.; Liso A.; Divero D.; Lo C...oco F.; Falini B. | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine | ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| CDK9/Cyclin T1 expression during normal lymphoid differentiation and malignant transformation. | Bellan C.; De Falco G.; Lazzi S.; Micheli P.; Vicidomini S.; Schürfels K.; Amato T.; Palumbo A.; ...Bagella L.; Sabattini E.; Bartolommei S.; Hummel M.; Pileri S.; Tosi P.; Leoncini L.; Giordano A. | 2004-01-01 | JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Acute renal failure in a young woman with Fisher-Evans’ syndrome. | De Sanctis B.A.; Mandrealo M.; Poggi C.; Pileri S.; Casanova S.; Santoro A. | 2004-01-01 | JN. JOURNAL OF NEPHROLOGY | - | 1.01 Articolo in rivista | - |
| Clinico-patholocal characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single instituion. | Breccia M., Mandelli F., Petti M.C., D’Andrea M., Pescarmona E., Pileri S.A., Carmosino I.,... Russo F., Fabritiis P.D., Alimena G. | 2004-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile